Use this form to refer patients with mild-moderate COVID-19 who are within 7 days of symptom onset, or when Pre-exposure prophylaxisis indicated.

Our outpatient COVID team will review for eligibility for any currently available treatment options: monoclonal antibodies, oral antivirals (Paxlovid), IV antivirals (remdesivir), or Evusheld (pre-exposure prophylaxis for high risk individuals).

When supply is limited, therapeutics will be allocated by a clinical priority system that preferences patients with highest risk for severe COVID disease.

Please call 413-795-0566 if you have questions.

Loading... Loading...
You have selected an option that triggers this survey to end right now.
To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.